Investors

Welcome to our Investor Relations

Here you’ll find everything you might be interested in if you want to invest in vibrant science and technology.

Upcoming Events

View All Events

Investor Related News

View All News
  1. Press Releases

    MilliporeSigma Launches First Ever AI Solution to Integrate Drug Discovery ...

    AIDDISON™ software-as-a-service platform bridges the gap between virtual molecule design and real-world manufacturing.

    2023/12/05

  2. Press Releases

    Merck KGaA, Darmstadt, Germany Provides Update on Phase III Results for Evobrutinib ...

    Two Phase III EVOLUTION clinical trials of evobrutinib did not meet their primary endpoints.

    2023/12/05

  3. Press Releases

    Merck KGaA, Darmstadt, Germany, Strengthens Oncology Portfolio Through Commercialization ...

    Merck KGaA, Darmstadt, Germany, today announced a license agreement with Abbisko Therapeutics for pimicotinib (ABSK021).

    2023/12/04

Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.

Check Share Price
investors-capital-market-day-us-Innovation Center investors-capital-market-day-us-Innovation Center
Capital Market Days
Learn More
Capital Market Days
At our Capital Market Days, our shareholders have the opportunity to meet our management and gain insights into our success story. We inform investors about our strategy, the latest financial developments and about our plans for the future.
IR Guidance IPad New US3 IR Guidance IPad New US3
Webcasts & Presentations
Learn More
Webcasts & Presentations
There is a large number of presentations and webcasts of different events available for download. They provide helpful insights into our company, our businesses and executives as well as our financial development.
Investors Annual General Meeting Us Investors Annual General Meeting Us
Annual General Meeting
Learn More
Annual General Meeting
Every year, our shareholders come together to make important decisions on our company’s business. We provide comprehensive material to help them make well-informed voting decisions.

RSS Feeds

Open one of the following links in a RSS feeder of your choice:

Get in touch!

We're here to help. Get in touch if you have any questions.

+49 6151 72 3321

+49 6151 72 91 3321